Corporate
Sep. 4, 2013
In India, local patent landscape keeps Western drugmakers on their toes
Recent policies and court decisions are causing headaches for Western drugmakers in some of the world's fastest growing markets. But for many, a string of rulings out of India are fast approaching migraine status.
Daily Journal Staff Writer
Recent regulatory policies and court decisions in some of the world's fastest growing drug markets are causing headaches for Western pharmaceutical companies. For many patent practitioners and in-house counsel, a string of rulings out of India that disallow patents for incremental innovations and uphold compulsory licenses are fast approaching migraine status.
Multinational drugmakers have l...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In